What is Swallowing Diagnostics?
Swallowing Diagnostics Inc. operates as a specialized provider of clinical swallowing assessments, deploying a mobile workforce of certified speech-language pathologists and physicians. The company addresses a critical gap in healthcare delivery by bringing state-of-the-art Modified Barium Swallow Studies (MBS) directly to healthcare facilities. By prioritizing expedient service and precise diagnostic interpretation, the firm serves as an essential partner for medical providers seeking to improve patient outcomes through accurate, on-site testing and actionable clinical recommendations.
How much funding has Swallowing Diagnostics raised?
Swallowing Diagnostics has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
Key Investors in Swallowing Diagnostics
PPP
Public-Private Partnership
What's next for Swallowing Diagnostics?
With the recent infusion of capital, Swallowing Diagnostics is poised to accelerate its market penetration and operational footprint. The strategic focus will likely center on upgrading diagnostic equipment and expanding the reach of its traveling clinical teams to meet the growing demand for specialized dysphagia management. As the company matures through its current growth phase, the emphasis will remain on maintaining high standards of clinical accuracy while optimizing the logistics of its mobile service model to better serve a broader network of healthcare facilities.
See full Swallowing Diagnostics company page
